期刊文献+

腹腔热化疗治疗胃癌性腹水的疗效研究 被引量:9

Application of intraperitoneal thermo-chemotherapy for the treatment of ascites of gastric cancer
下载PDF
导出
摘要 目的探讨胃癌腹水应用顺铂、5-氟尿嘧啶(5-FU)序贯腔内给药治疗,同时联合内生场热疗的疗效。方法选取2009-2012年吉林省肿瘤医院腹部肿瘤外二科收治的胃癌性腹水患者76例,按不同治疗方法分为治疗组(39例)和对照组(37)例。治疗组:腹腔内化疗,每周1次,联合局部内生场热疗,每周2次;连续治疗2周后休息1周。对照组:单纯腹腔内化疗,每周1次。观察两组患者的疗效和不良反应。结果治疗组患者有效率为89.74%,而对照组为67.57%,两组间比较差异有统计学意义(P<0.05)。两组患者治疗后不良反应主要表现为恶心、食欲下降、乏力,偶见低热、腹痛和一过性白细胞下降,且均在可控范围内。结论腹腔内化疗联合内生场热疗能有效地控制胃癌性腹水,不良反应较轻。 Objective To explore the efficacy of cisplatin and 5-fluorouracil(5-FU)sequential administration of the treatment cham- ber, while the joint effect of hyperthermia within the field of health, for the treatment of malignant ascites suffered from gastric canc- er. Methods Totally 76 patients received from 2009 to 2012 in our department were analyzed in this study. In the treatment group (39 cases) , 1 time per week intraperitoneal chemotherapy combined with local was performed ,2 times a week;continuous treatment for 2 weeks after 1 week rest. While, in the control group (37 cases), simple intraperitoneal chemotherapy was performed, once a week. The efficacy and adverse reactions were observed in all cases of the two groups. Results The effective rate was 89.74% in the treatment group,while that was 67.57% in the control group, and there was statistical difference between the 2 groups( P 〈 0.05 ). Side effects were mainly nausea,loss of appetite, fatigue, occasional fever, abdominal pain and transient leukopenia. Conclu- sion Intraperitoneal chemotherapy combined with hyperthermia within the field of health can effectively control the field of hyper- thermia cancer ascites,reducing adverse reactions. Thermo-chemotherapy can improve local and systemic cellular immune function and may inhibit tumor angiogenesis effect.
出处 《临床军医杂志》 CAS 2015年第7期729-732,共4页 Clinical Journal of Medical Officers
关键词 胃癌性腹水 顺铂 5-氟尿嘧啶 内生场热疗 Malignant ascites Cisplatin 5-fiuorouracil Endogenous field hyperthermia
  • 相关文献

参考文献14

二级参考文献29

  • 1何华,刘齐宁,王惠芳,候敏全.两种治疗方法对老年恶性胸腔积液疗效的对比研究[J].中国现代医学杂志,2004,14(23):89-91. 被引量:6
  • 2曹培国,张隽,唐又群,姚志平,张震,潘宇亮.86例恶性体腔积液的热化综合治疗[J].临床肿瘤学杂志,2005,10(2):148-151. 被引量:16
  • 3于安伦,于金明.热疗的临床应用进展[J].国外医学(肿瘤学分册),1996,23(4):235-237. 被引量:16
  • 4王伟,李迎新,李丰彤,王海磐.肿瘤热疗热剂量仪的研制[J].医疗卫生装备,2006,27(4):7-9. 被引量:1
  • 5[1]Robins HI, Grosen E, Katschinski DM et al. Whole body hyperthermia induction of soluble tumor necrosis factor receptors: implications for rheumatoid disease [J]. J Rheumatol, 1999, 26(12):2513-2516. 被引量:1
  • 6[2]Katschinski DM, Benndorf R, Wiedemann GJ et al. Heat shock protein antibodies in sarcoma patients undergoing 41.8 C whole body hyperthermia[J]. J Immunother, 1999, 22(1):67-70. 被引量:1
  • 7[3]Morita M, Kuwano H, Araki K et al. Prognostic significance of lymphocyte infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer[J]. Int J Radiat Oncol Biol Phys, 2001, 49(5):1259-1266. 被引量:1
  • 8[4]Masunaga S, Ono K, Takahashi A et al. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status[J]. Cancer Sci, 2003, 94(1):125-133. 被引量:1
  • 9[5]Roca C, Primo L, Valdembri D et al. Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism[J]. Cancer Res, 2003, 63(7):1500-1507. 被引量:1
  • 10[6]Ressel A, Weiss C, Feyerabend T. Tumor oxygenation after radiotherapy, chemotherapy, and/or hyperthermia predicts tumor free survival[J]. Int J Radiat Oncol Biol Phys, 2001, 49(4):1119-1125. 被引量:1

共引文献84

同被引文献124

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部